Related Experiment Video
Updated: Feb 27, 2026

07:07
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
3.9K
Measurement of pO2 in a Pre-clinical Model of Rabbit Tumor Using OxyChip, a Paramagnetic Oxygen Sensor
H Hou1, N Khan1, P Kuppusamy2
1Department of Radiology, Geisel School of Medicine at Dartmouth College, Rubin 601, 1 Medical Center Drive, Lebanon, NH, 03756, USA.
Advances in Experimental Medicine and Biology
|July 8, 2017
Summary
Electron paramagnetic resonance (EPR) oximetry using OxyChip enables practical tumor oxygen measurement. This novel technology provides noninvasive, repeated pO2 readings in pre-clinical large animal models.
Area of Science:
- Biomedical Engineering
- Medical Physics
- Pre-clinical Research
Background:
- Accurate tumor oxygen (pO2) measurement is crucial for cancer research and treatment.
- Electron paramagnetic resonance (EPR) oximetry offers a potential method for pO2 sensing.
- Previous development of oxygen-sensing paramagnetic crystals (LiNc-BuO) in a polymer (OxyChip) has been reported.
Purpose of the Study:
- To establish electron paramagnetic resonance (EPR) oximetry with OxyChip as a robust technology for practical tumor oxygen measurement.
- To validate the use of OxyChip for noninvasive pO2 measurements in a pre-clinical large-animal model.
Main Methods:
- Development of oxygen-sensing paramagnetic crystals (LiNc-BuO) encapsulated in a biocompatible polymer (OxyChip).
- Application of OxyChip for pO2 measurements in the tumor of a pre-clinical, large-animal rabbit model.
- Utilizing EPR oximetry principles for signal detection and quantification.
Main Results:
- OxyChip successfully enabled pO2 measurements in a large-animal tumor model.
- The technology demonstrated capability for noninvasive and repeated measurements.
- Data confirms the feasibility of EPR oximetry for in-vivo tumor oxygen monitoring.
Conclusions:
- OxyChip, based on EPR oximetry, is a practical tool for measuring tumor oxygen.
- The technology is validated for noninvasive and repeated pO2 measurements in a pre-clinical large-animal model.
- This approach holds promise for advancing cancer research and therapeutic monitoring.

